Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin
- PMID: 27138212
- DOI: 10.1007/s00595-016-1335-3
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin
Abstract
Background and purpose: The long-term survival of patients with peritoneal carcinomatosis of colorectal origin has been achieved with cytoreductive surgery, which removes all macroscopic implants, combined with hyperthermic intraperitoneal chemotherapy (HIPEC). The current technology for administering intraperitoneal heated chemotherapy is expensive and, for some institutions, unaffordable. We conducted this study to assess the temperature stability provided by a modified, inexpensive system, to offer a simple and low cost alternative to the standard HIPEC delivery equipment.
Methods: Ten patients with histologically diagnosed peritoneal metastases of adenocarcinoma or pseudomyxoma peritonei underwent cytoreductive surgery and received HIPEC with 5-fluorouracil for 90 min, delivered via our modified system. The temperature was recorded from two probes: one in the inflow catheter and one in the outflow catheter. The intra-abdominal temperature was monitored meticulously to maintain it at between 41 and 42 °C.
Results: All patients underwent cytoreductive surgery and HIPEC using our modified delivery system. Temperature stability was achieved in all patients, with a mean of 41.4°. There were no thermal injuries associated with any of the ten perfusions. The mean hospital stay was 15 days and the median survival was 30 months.
Conclusion: Analysis of this data demonstrates that the uniform delivery of HIPEC at 41° with this modified system is feasible and safe. The outcome of the patients treated with cytoreductive surgery and HIPEC with this modified system compares favorably to other published series. Its low cost and simple design will give more patients with peritoneal carcinomatosis access to this treatment.
Keywords: Cytoreduction; Intraperitoneal hyperthermic chemotherapy; Peritoneal carcinomatosis; Peritonectomy; colorectal cancer.
Similar articles
-
Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).Updates Surg. 2020 Sep;72(3):923-924. doi: 10.1007/s13304-020-00842-2. Epub 2020 Jun 29. Updates Surg. 2020. PMID: 32602012 No abstract available.
-
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.Eur J Surg Oncol. 2015 Apr;41(4):466-71. doi: 10.1016/j.ejso.2015.01.018. Epub 2015 Jan 29. Eur J Surg Oncol. 2015. PMID: 25680955
-
Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.Int J Hyperthermia. 2014 Dec;30(8):565-9. doi: 10.3109/02656736.2014.974693. Int J Hyperthermia. 2014. PMID: 25430988
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.Asian J Surg. 2021 Jan;44(1):221-228. doi: 10.1016/j.asjsur.2020.05.010. Epub 2020 Jun 27. Asian J Surg. 2021. PMID: 32605790 Review.
-
[Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].Minerva Chir. 2002 Oct;57(5):597-605. Minerva Chir. 2002. PMID: 12370661 Review. Italian.
Cited by
-
Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research.Gastroenterol Res Pract. 2019 Apr 1;2019:5180895. doi: 10.1155/2019/5180895. eCollection 2019. Gastroenterol Res Pract. 2019. PMID: 31065262 Free PMC article. Review.
-
A Modified Low-Cost Technique of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Two Patients: a Solution for Pseudomyxoma Peritonei in the Indian Scenario?J Gastrointest Cancer. 2019 Dec;50(4):983-990. doi: 10.1007/s12029-018-0161-9. J Gastrointest Cancer. 2019. PMID: 30140971 No abstract available.
-
Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer.J Clin Med. 2018 Dec 19;7(12):567. doi: 10.3390/jcm7120567. J Clin Med. 2018. PMID: 30572653 Free PMC article. Review.
-
Hyperthermic intraperitoneal chemotherapy following up-front cytoreductive surgery versus cytoreductive surgery alone for isolated synchronous colorectal peritoneal metastases: A retrospective, observational study.Front Oncol. 2022 Oct 18;12:959514. doi: 10.3389/fonc.2022.959514. eCollection 2022. Front Oncol. 2022. PMID: 36330501 Free PMC article.
-
Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study.Medicine (Baltimore). 2020 Aug 14;99(33):e21546. doi: 10.1097/MD.0000000000021546. Medicine (Baltimore). 2020. PMID: 32872001 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical